Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Performance Evaluation of Dream OCT: AP Study

NCT: NCT07355491 · COMPLETED

NCT IDNCT07355491
StatusCOMPLETED
Start Date2025-12-16
Completion2026-05-12
SponsorIntalight, Inc (INDUSTRY)
First posted
Last updated

Brief Summary

This study will evaluate the clinical performance of a new swept-source OCT imaging device, the VG200D, and to evaluate substantial equivalence with a predicate device, the Cirrus 5000. Clinical performance will be assessed through an agreement and precision analysis of OCT measurement parameters.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑